Traders Buy High Volume of Schrodinger Call Options (NASDAQ:SDGR)

Schrodinger, Inc. (NASDAQ:SDGR) was the target of unusually large options trading on Thursday. Stock investors purchased 4,268 call options on the company. This represents an increase of approximately 412% compared to the typical volume of 834 call options.

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of the business. Integrated Wealth Concepts LLC bought a new stake in shares of Schrodinger in the second quarter worth $102,000. Squarepoint Ops LLC boosted its stake in Schrodinger by 290.4% during the 2nd quarter. Squarepoint Ops LLC now owns 209,123 shares of the company’s stock valued at $3,398,000 after acquiring an additional 155,556 shares during the last quarter. Allworth Financial LP grew its holdings in Schrodinger by 252.3% during the 2nd quarter. Allworth Financial LP now owns 5,270 shares of the company’s stock worth $86,000 after acquiring an additional 3,774 shares in the last quarter. Corient Private Wealth LP acquired a new position in Schrodinger during the 2nd quarter worth $303,000. Finally, Beacon Pointe Advisors LLC bought a new stake in shares of Schrodinger in the 2nd quarter worth about $839,000. Institutional investors and hedge funds own 79.05% of the company’s stock.

Schrodinger Price Performance

NASDAQ SDGR traded up $3.93 on Thursday, reaching $27.86. The company had a trading volume of 2,833,152 shares, compared to its average volume of 1,336,640. The firm has a market capitalization of $2.06 billion, a PE ratio of -37.62 and a beta of 1.69. Schrodinger has a 1 year low of $10.94 and a 1 year high of $28.63. The firm has a 50-day moving average of $17.99 and a 200-day moving average of $14.96.

Schrodinger (NASDAQ:SDGR) last announced its earnings results on Wednesday, August 5th. The company reported $0.08 earnings per share for the quarter, beating the consensus estimate of ($0.41) by $0.49. Schrodinger had a negative net margin of 20.98% and a negative return on equity of 16.37%. The business had revenue of $58.89 million during the quarter, compared to the consensus estimate of $47.19 million. During the same period in the prior year, the firm earned ($0.65) earnings per share. The business’s quarterly revenue was up 7.5% compared to the same quarter last year. As a group, sell-side analysts expect that Schrodinger will post -1.5 EPS for the current fiscal year.

Analyst Ratings Changes

SDGR has been the topic of a number of recent research reports. Wall Street Zen raised shares of Schrodinger from a “strong sell” rating to a “hold” rating in a research report on Saturday, August 8th. UBS Group initiated coverage on shares of Schrodinger in a research note on Friday, August 14th. They issued a “neutral” rating and a $19.00 target price on the stock. Finally, Weiss Ratings upgraded shares of Schrodinger from a “sell (e+)” rating to a “sell (d-)” rating in a report on Thursday, August 27th. Three equities research analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus price target of $20.50.

Schrodinger Company Profile

Schrödinger, Inc develops computational software designed to accelerate drug discovery and materials science research. Its platform uses physics-based modeling, machine learning and related computational methods to help scientists analyze molecular structures, predict interactions and identify potential compounds for further development.

The company’s software products support a range of research activities, including molecular modeling, virtual screening, structure-based drug design, free-energy calculations and collaborative data management.